The transcriptional program regulated by the tumor suppressor p53 was analysed using oligonucleotide microarrays. A human lung cancer cell line that expresses the temperature sensitive murine p53 was utilized to quantitate mRNA levels of various genes at dierent time points after shifting the temperature to 328C. Inhibition of protein synthesis by cycloheximide (CHX) was used to distinguish between primary and secondary target genes regulated by p53. In the absence of CHX, 259 and 125 genes were up or down-regulated respectively; only 38 and 24 of these genes were up and down-regulated by p53 also in the presence of CHX and are considered primary targets in this cell line. Cluster analysis of these data using the super paramagnetic clustering (SPC) algorithm demonstrate that the primary genes can be distinguished as a single cluster among a large pool of p53 regulated genes. This procedure identi®ed additional genes that co-cluster with the primary targets and can also be classi®ed as such genes. In addition to cell cycle (e.g. p21, TGF-b, Cyclin E) and apoptosis (e.g. Fas, Bak, IAP) related genes, the primary targets of p53 include genes involved in many aspects of cell function, including cell adhesion (e.g. Thymosin, Smoothelin), signaling (e.g. H-Ras, Diacylglycerol kinase), transcription (e.g. ATF3, LISCH7), neuronal growth (e.g. Ninjurin, NSCL2) and DNA repair (e.g. BTG2, DDB2). The results suggest that p53 activates concerted opposing signals and exerts its eect through a diverse network of transcriptional changes that collectively alter the cell phenotype in response to stress.
The transcriptional program regulated by the tumor suppressor p53 was analysed using oligonucleotide microarrays. A human lung cancer cell line that expresses the temperature sensitive murine p53 was utilized to quantitate mRNA levels of various genes at dierent time points after shifting the temperature to 328C. Inhibition of protein synthesis by cycloheximide (CHX) was used to distinguish between primary and secondary target genes regulated by p53. In the absence of CHX, 259 and 125 genes were up or down-regulated respectively; only 38 and 24 of these genes were up and down-regulated by p53 also in the presence of CHX and are considered primary targets in this cell line. Cluster analysis of these data using the super paramagnetic clustering (SPC) algorithm demonstrate that the primary genes can be distinguished as a single cluster among a large pool of p53 regulated genes. This procedure identi®ed additional genes that co-cluster with the primary targets and can also be classi®ed as such genes. In addition to cell cycle (e.g. p21, TGF-b, Cyclin E) and apoptosis (e.g. Fas, Bak, IAP) related genes, the primary targets of p53 include genes involved in many aspects of cell function, including cell adhesion (e.g. Thymosin,
Introduction
The function of p53 as tumor suppressor is mainly due to its activity as a transcription factor that activates many genes in response to various types of stress (ElDeiry et al., 1992) . This may be the basis for p53 protection of cells against DNA damage and various stress conditions that lead usually to growth arrest or apoptosis (Levine, 1997) . Mice with p53 which was rendered transcriptionally inactive by mutations at codon 25 and 26 are predisposed to tumors similar to p53 de®cient mice (Jimenez et al., 2000) , demonstrating the importance of transcriptional activity for p53 function. The heterogeneity of gene transcription pro®le in response to p53 was demonstrated recently using transcriptionally regulated p53 expressed in colon cancer cell line (Zhao et al., 2000; Yu et al., 1999) . This heterogeneity could result partly from secondary eect and from dependence on other transcription factors. In order to overcome part of this heterogeneity and to distinguish primary targets of p53, we used the temperature sensitive p53 (denoted Val135) (Michalovitz et al., 1990) expressed in the human lung cancer cell line H1299 to analyse the transcriptional programs induced by p53. Shifting the temperature to 328C causes Val135 to assume wild-type p53 conformation and induce target genes. This conformational change does not require protein synthesis and allows for the analysis of p53 induced genes in the presence of protein synthesis inhibitor to prevent secondary eects brought about by the activated genes.
Here we analysed the pro®le of gene expression regulated by p53 at 328C in the presence and absence of cycloheximide (CHX) using DNA microarrays containing *7000 probes for human genes (Aymetrix, Santa Clara, USA). Less than 20% of the genes regulated by p53 were also regulated in the presence of CHX and therefore are de®ned as primary targets of p53. We were able to distinguish these genes as a cluster of primary targets among a large pool of p53 regulated genes by subjecting the expression data to clustering analysis using Super Paramagnetic Clustering (SPC) algorithm (Blatt et al., 1996) . The results indicate that in addition to genes involved in cell cycle control and apoptosis, p53 regulates directly a plethora of genes involved in many aspects of cellular functions such as DNA repair, cytoskeleton, extracellular matrix and signal transduction. This suggests that in addition to its eect on cell cycle, p53 may exert some of its tumor suppressive eects through a diverse network of transcriptional changes that alter cellular phenotype and behavior in response to stress.
Results

Effect of cycloheximide on p53 target genes
Analysis of mRNA from H1299Val135 cells and H1299 control cells by hybridization to DNA microarrays showed that after 12 h at 328C, 212 and 77 genes were up and down-regulated respectively by more than 2.5-fold. It is likely that some of these genes may be regulated because of secondary eects induced by the primary targets of p53. To identify the primary targets, we analysed the eect of p53 in the presence and absence of cycloheximide (CHX) at 328C in both H1299Val135 and H1299 control cells. The inhibition of protein synthesis by CHX presumably prevents most of the seconday gene regulation (O'Hagan et al., 2000; Coller et al., 2000) that is not transactivated directly by p53. The results showed that in the presence of CHX, p53 remained stable for at least 12 h ( Figure 1A ) and induce signi®cantly the mRNA of p21waf, a major target for p53 ( Figure 1B ). Evidently protein synthesis was indeed shut down as no p21waf or hDM2 (human MDM2) proteins were detected, in contrast to their presence in the experiment without CHX ( Figure  1C,D) . It was shown previously that at 328C p53Val135 is relocalized to the nucleus (Ginsberg et al., 1991) and that it may therefore be protected from degradation in the presence of CHX due to a lack of nuclear exclusion and the absence of hDM2 synthesis (Haupt et al., 1997; Kubbutat et al., 1997) . Hence, direct target genes of p53 will be transcriptionally activated, but because of inhibition of protein synthesis, the p53-induced proteins will not be synthesized and will not induce secondary or indirect p53 target genes.
p53 primary target genes identified in the presence of cycloheximide RNA from various time points (between 2 to 24 h) was isolated, labeled and hybridized to oligonucleotide microarrays (Genechip Hugene FL array, Aymetrix, Santa Clara, USA) which contains probes for *7000 human genes. Those genes that are transcriptionally regulated by p53 under both conditions, i.e. with and without CHX, are likely to be primary targets for p53-mediated transcription. In order to eliminate noisy data in the analysis of the hybridization experiments, we applied a very stringent ®lter; we selected genes that showed more than 2.5-fold induction or repression (over their controls) at three or more time points in the presence or absence of CHX. Two hundred and ®fty-nine upregulated genes passed this ®lter for the experiment in the absence of CHX whereas 131 genes passed this ®lter for the experiment with CHX; 38 genes were found to be common to these two groups (see the Venn diagram in Figure 2A and Table  1 ). Denote by G(38) the group of 38 genes that have been identi®ed by our analysis as possible primary upregulated targets of p53. It is important to note that n=38, the number of these genes, exceeds signi®cantly the number n r , that would have been obtained had we applied the same ®ltering procedure to random data. To estimate n r , assume that for every gene in any single experiment, the over-expression level can exceed 2.5 with probability P, and that such over-expressions are independent random events. All together, nine measurements were taken for 7070 genes; by counting the number of occurrences of 2.5-fold over-expression, we estimate P&0.053. The probability that a particular gene will be over-expressed at least three times at a level above 2.5 in the experiments without CHX is 5.7´10 
77
. Multiplying these probabilities by the total number of genes tested, we get estimates for the numbers of genes that would have passed the ®lter and would have been assigned to the three groups. Next to these estimates, which represent the expected number of genes for random expression data, i.e. for a randomized expression matrix, we placed in parentheses the actual numbers, obtained by our analysis for the real data: with CHX: 10 (vs 131); without CHX: 4 (vs 259); and the number of genes expected to be in the overlap; n r =5´10
73
(vs 38). The large disparity between the numbers obtained under the assumption of a random process and the actual measured numbers proves beyond doubt the statistical signi®cance of our ®ndings.
The down-regulated genes that passed this ®lter were 146 and 219 respectively in the experiments without and with CHX and 24 genes were common to these groups ( Figure 2B ). The common genes were regulated by p53 irrespective of the presence or absence of CHX (Tables 1 and 2 ). The remaining 218 upregulated and 121 downregulated genes (Figure 2 ) may be indirect or secondary targets of p53 (see Table at our web site: http://www.weizmann.ac.il/home/ligivol/primary.html). In this study, we focus mainly on the analysis of the upregulated genes. Apparently CHX by itself also induced many genes probably due to removal of inhibitory signals for gene expression or changes in gene expression associated with clonal variability. Had we performed the analysis of p53 induced genes only in the presence of CHX, we would have detected 131 genes ( Figure 2A ) as primary targets, most of which may be unrelated to direct p53 regulation.
In order to analyse genes regulated by CHX in the absence of p53, H1299 cells were incubated at 328C in the presence of CHX and RNA was collected at 2 and 6 h and analysed by hybridization to the DNA microarray. Three genes from the 38 primary upregulated genes (Table 1) were also upregulated by CHX alone. These are the ATF3 (activated transcription factor 3), Histone 2A like protein and Bak. In a similar way the eect of temperature on H1299 cells was analysed by incubating H1299 cells at 328C and collecting RNA for hybridization at 2 and 12 h. Three genes from the primary genes: Lysyl oxidase, Diacylglycerol kinase and LISCH7 were found to be upregulated also after 12 h at 328C. We keep these genes in the primary target list although they were upregulated by the control conditions (CHX or temperature). It is possible that these genes are transactivated by various stress conditions as well as by p53. For example, p21 waf1 , a major primary target of p53 is also induced by a variety of external stimuli and stress conditions independent of P53 (Michieli et al., 1994) .
Identifying primary p53 target genes by cluster analysis
A major problem we must now face is that the identities of the genes of G(38), that were designated above as possible primary upregulated targets of p53, are determined by our stringent ®ltering criteria. Had we set our threshold at, say, observing twofold increased expression (instead of 2.5) at two time points (instead of three), the number of genes that passed the ®lter would have been larger. The values of our ®ltering parameters (2.5-fold change at three or more times, in both experiments) were chosen in an arbitrary fashion; it is important to assess the extent to which relaxation of our ®ltering criteria will add primary p53 target genes beyond the 38 candidates that were already found. In order to reduce the dependence of our results on the precise values of the arbitrarily chosen ®ltering parameters, we performed cluster analysis on the data, using more relaxed ®ltering criteria to select the genes to be included in the analysis.
The ®rst cluster analysis was done on the 259 genes that passed our ®lter for the experiment without CHX. That is, in our ®ltering we relaxed completely the restriction on the expression levels measured in the experiment with CHX (but did use the results of these experiments in the cluster analysis). Each of the 259 genes is represented by its expression levels taken at nine dierent time points (in the two experiments combined). The data were normalized as follows. Denote by A ij the log 2 ratio of the expression of gene i (where i=1,2,...,259), measured at experiment (and time) j (with j=1,2,...,9), with respect to the control. For j=1,...,4 we divided A ij by 4 j1 A 2 ij 1a2 and for Figure 2 Venn diagram of the number of genes that were regulated by p53 in the presence and absence of CHX. (A) Only genes that showed at least 2.5-fold up or (B) down-regulation in at least three of the time points in each experiment i.e. with or without CHX, were listed in this analysis. Note that only 38 of the up-regulated and 24 of the down-regulated genes were unaected by CHX (Blatt et al., 1996; Getz et al., 2000) (see below). Genes with similar expression pro®les (over the time courses of both experiments) are represented by two nearby vectors and are placed in the same cluster. This cluster analysis answers directly two questions: (1) Do all, or a majority of the genes of G(38) cluster together?; and (2) What other genes cluster together with these possible primary targets? If the answer to the ®rst question is positive, we can identify an expression pro®le which is characteristic of primaries, and identify those genes that share this pro®le and cluster together with the genes of G(38) as good candidates for being primaries (even though they did not pass the original stringent ®ltering process). Furthermore, if we ®nd that some of the members of G(38) have signi®cantly dierent expression kinetics than this characteristic pro®le, these genes should possibly be removed from the list of primaries.
Regarding the ®rst question ± the genes of G(38) are special in that their expression increased at least 2.5-fold at three or more time points of both The 24 genes that were downregulated in either the presence of absence of CHX Primary targets are de®ned as genes that changed their expression over 2.5-fold in at least three time points in the presence and absence of cycloheximide (CHX). The ratio of gene expression was determined by the expression level at each time point divided by that of H1299 contol cells at 2 h at 328C. The list denoted G(38) consists of the genes in the overlap in Figure 2 . The list denoted G(47) constitutes the set of primary p53 targets generated from the cluster analysis in Figure 3 (see text) . The list denoted G(9) contains the genes in cluster a in Figure 3A experiments. Hence their representative 9-component vectors are likely to be close ± but some may also be uncorrelated. For example, a gene whose expression decreases with time will have low correlation with one that increases. This situation may happen even if both genes passed the ®ltering criteria. The results of our cluster analysis are summarized in the dendrogram of Figure 3A . The parameter T on the horizontal axis controls the resolution at which the data are viewed. At T=0 all 259 genes are in a single cluster; as T increases, large groups split into smaller ones. The boxes indicate clusters that contain more than four genes. Each box is colored according to its purity' ± the percentage of members of G(38) among the genes contained in the corresponding cluster.
When we reorder the genes according to their position in the dendrogram, i.e. rearrange the rows of the expression data matrix according to the order imposed by the clustering process, the color-codedmatrix of Figure 3B is obtained.
Next, we marked the positions of the members of G(38) by red crosses. All 38 are in the low-level cluster Figure 3 Clustering results using super-paramagnetic clustering (SPC) for the 259 genes that were upregulated at three time points or more upon activation of p53 in the experiment without cycloheximide (CHX). (A) The dendrogram of the genes that include clusters of size 4 and larger. Each cluster is represented by a box colored according to the per cent of primary target genes (38 genes, see Table 1 ) contained in the cluster. The distribution of the 38 primary target genes is marked by red crosses at the right. (B) The normalized log ratio of the nine experiments (four without CHX and ®ve with CHX) are plotted. The genes are ordered according to the dendrogram on the left. The color represents induction (red) or repression (blue). T, a parameter of the SPC algorithm that controls the resolution at which the cluster is found. %, per cent of primary target genes in the cluster. The cluster marked by an arrow (c) contains 87% of the 38 primary genes. The cluster marked by b contains all the 38 primary genes and the cluster marked by a contains the nine genes that show dierent kinetics (Table 1 and Figure 3A . The expression pro®le of each gene in the cluster was normalized as described in the text denoted by b which, however, contains also 58 additional genes. This cluster branches and breaks into sub-clusters which have higher percentages of genes from G(38). In order to identify a characteristic primary expression pro®le we want to work with a cluster which has many members of G(38) (for better statistics) and also has a high percentage of them. These two requirements con¯ict; as we move up on the dendrogram, the clusters become purer, but also decrease in size. Hence we decided to start with the cluster c marked by the arrow as our working point. It contains 33 of the G(38) genes and, in addition, 23 genes that did not pass the original ®lter, but have expression pro®les that are similar to those of G(38).
The average expression kinetics of the genes of this cluster in the two experiments is shown in Figure 4 . Note the fairly similar kinetics with and without CHX, with the expression level increasing monotonously with time. All but nine genes of c share these features of the expression kinetics. The nine which dier appear on the dendrogram in the vicinity of the cluster denoted by a; two of these belong to G(38). The average expression kinetics of these nine genes is shown in Figure 5 Clustering results using superparamagnetic clustering (SPC) for 1090 genes that were upregulated in the experiment without cycloheximide. In this analysis a relaxed ®ltering condition was used and all the genes that were upregulated 2.5-fold at least once (1090) Figure 4 (top panel), and their kinetics with and without CHX are dierent. Hence we decided to discard these nine genes from our list of designated primaries. The average expression kinetics of the remaining 47 genes is very similar to Figure 4 , with reduced scatter (error bars). The group of these 47 genes, denoted G(47), constitutes our ®nal set of proposed primary p53 targets (Table 1) .
This analysis identi®ed a characteristic kinetic pro®le of primary p53 targets in either the presence or absence of CHX; the group of genes that share this pro®le contains 31 out of our 38 original candidates and 16 additional ones, that happened to fail our stringent ®ltering criteria. The various genes are listed and the groups to which they belong are properly identi®ed in Table 1 .
Some of the known p53 target genes such as Gadd45 (Zhan et al., 1998) and PCNA (Shivakumar et al., 1995) , were now included as primary targets in addition to the original 38 primary target genes, indicating that this is a sensible way to`®sh' for further potential primary targets. Most of these added genes exhibited *twofold induction at several of the time points both in the presence or absence of CHX experiments and were previously not known to be p53 target genes.
Next, we have put the stability of our identi®cation of primary p53 targets against changing the procedure and parameters of selection to an extremely demanding test. We performed a similar cluster analysis on a much larger set of genes, including now all those that were upregulated at least twofold, at (at least) a single time point of the experiment without CHX. This very relaxed criterion selected 1090 genes to cluster; that is, as compared to the previous clustering analysis, the number of genes was increased fourfold, including now extremely noisy expression data. The results obtained when these 1090 genes were clustered are presented in Figure 5 . To our satisfaction, we found that 3/4 of our 47 proposed primary p53 targets (that were identi®ed above), belong to two very stable gene clusters, denoted by arrows on Figure 5A . The left of the two contains 24 of the genes of G(47) and 20 new genes, whereas the right one contains 11 from G(47) and seven new associated genes. The average expression kinetics of the two clusters is shown in Figure 6 .
It is important to understand that adding all these extra noisy genes to the set of 259 that were analysed before could well have resulted in a total loss of the signal that was identi®ed above. The fact that the two clusters that are rich in previously identi®ed primaries indeed contain 35 out of the 47 is gratifying and indicates the stability of our method.
Finally, we turn to discuss our choice of the clustering algorithm to be used (SPC) (Blatt et al., 1996; Getz et al., 2000) . The optimal algorithm for analysis of gene expression data should have the following properties: the number of clusters should be determined by the algorithm itself and not externally prescribed (as is done for SOM and K-means) (Sherlock, 2000; Young, 2000) ; stability against noise; generating a hierarchy (dendrogram) and providing a mechanism to identify in it robust, stable clusters; ability to identify a dense set of points, that form a cloud of an irregular, non-spherical shape, as a cluster. SPC, a hierarchical clustering method recently introduced by Blatt et al. (1996) is the algorithm that best ®ts these requirements.
Discussion
In this study we have used the temperature sensitive p53 expressed in the lung cancer cell line H1299 to analyse p53-regulated genes utilizing oligonucleotide microarray containing 7070 probes. We employed inhibition of protein synthesis by CHX in an eort to limit the p53-regulated genes to primary targets by exclusion of possible secondary eect by newly synthesized proteins. By measuring gene expression at four or ®ve time points we clearly show that a group of genes show consistent p53-dependent regulation in either presence or absence of CHX. This group consists of less than 20% of the genes regulated by p53 in the absence of CHX, and de®ned here as primary targets. The criteria used to group these genes (2.5-fold change in at least three time points) is somewhat arbitrary and may discriminate against genes which show consistent changes but did not reach the 2.5-fold change in all the time points analysed. We therefore used a clustering method which allows the grouping of genes based on the kinetics of their expression and showed that most of the primary genes group together in one or two clusters. These clusters contain additional genes which show similar kinetic behaviors in their change of expression even though their level of expression did not search the stringent criteria. This group contains some of the established targets of p53 (e.g. Gadd45 and PCNA) and demonstrate the usefulness of this clustering method, since it overcame small experimental variation in measurement of hybridization intensity and relies on the pattern of expression in the presence or absence of CHX.
In order to compare our results with known p53 targets we used the list compiled by El-Deiry (1998) . Some of the genes in this list are not present on the chip (Bax, Killer/DR5, PAG608, 14-3-3s and B99). From the rest of the p53 targets on this list p21waf, Fas/Apo, Gadd45 and PCNA were detected as primary target genes (Table 1) . MDM2 (a known p53 target) expression was increased more than 2.5-fold after 4 h in the presence of CHX but reached 2.67-fold expression only after 24 h without CHX. CyclinG expression level reached 2.4-fold only after 12 h in CHX and 2.1-fold after 12 h without CHX. Cathepsin D, Thrombospondin, IGFBP5 and PI3 kinase were not over pressed in this cell line in our experiment. This type of heterogeneity of expression indicates that not all p53-targets are activated in all conditions and a similar conclusion was pointed out also by other studies (Yu et al., 1999; Zhao et al., 2000) . We also tried to analyse for the presence of p53 consensus targets in several of the genes listed in Table 1 . This was performed by searching for the sequence of the two consensus decamers RRRCWWGYYY, separated by a gap of 0 ± 13 nucleotides, in the sequence which is 2 kbp upstream and downstream to the RNA start. In our list of primary targets, seven genes were shown previously to have consensus sequence and their promoters respond to p53; 15 genes were found to have consensus p53 targets with up to two mismatches and ®ve genes did not have the genomic sequence available yet (data not shown). We feel that database search that is not supported by experimental analysis of individual genes is not very informative at present.
Our results from the analysis of p53 regulated primary target genes show that p53 directly upregulates proapoptotic and cell cycle inhibitors (e.g. Bak and p21waf) (see Table 1 ) and downregulates antiapoptotic and cell cycle genes (e.g. Inhibitor of Apoptosis and Cyclin E) (see Table 2 ). Thus p53 seems to activate concerted opposing signals to control cell proliferation and apoptosis. Although the identi®ed primary genes cluster together, indicating the similarity in their expression kinetics, functional classi®cation of these genes revealed that they are very dierent in their cellular activities (Table 1 ). The genes involved in cell cycle, growth arrest, apoptosis and perhaps DNA repair seem to be activated in most cell types analysed (e.g. p21waf, Fas/ApoI, bcl2 binding protein) (Zhao et al., 2000; Komarova et al., 1998) . On the other hand, genes involved in many other cellular functions like cytoskeleton, extracellular matrix (ECM), growth factors and their receptors and signal transduction may be more speci®c to the cell type analysed and this may be one of the causes for dierent lists of p53 regulated genes in various cells lines as was pointed out previously (Zhao et al., 2000; Yu et al., 1999) . For example, in H1299 cells we found activation of several genes known to be involved in neuronal growth (Table  1) which may be unique to this cell type.
Several reasons may account for the heterogeneity of p53 target genes. It is possible that some of the targets require additional factors as coactivators. For example the transactivation of the mismatch repair gene MSH requires both p53 and c-jun or UV irradiation (Scherer et al., 2000) . An additional factor may be the level of p53 activation by phosphorylation and other posttranslation modi®cation. Dierent transactivation properties may be related to a dierent level of p53 modi®cation (Vousden, 2000; Oda et al., 2000) .
We have noted before the induction of TGFb by p53 (Kannan et al., 2000) and another study con®rmed that TGF-b is a primary target of p53 and demonstrated its growth suppressor activity (Tan et al., 2000) . This was also evident in our current experiments and may potentially suggest an additional paracrine mechanism by which p53 exerts its tumor suppressive eects on neighboring tumor cells. Other genes in our list of primary genes like endoglin (a coreceptor of TGF-b) and versican may also be part of the TGF-b activating system (Massague et al., 2000) . Interestingly, the tumor suppressor activity of TGF-b may be related mainly to its function as an inducer of p15 (ink4b) expression (Hannon and Beach, 1994) . The p15 is an inhibitor of cdk4 and cdk6 and its overexpression may lead to G1 arrest (Massague et al., 2000) , thus TGF-b may behave as a tumor suppressor (Tang et al., 1998) . The induction of p21waf by p53 and p15 by TGF-b which itself is a target of p53 may provide an ecient control on the cell cycle. In the H1299 cell line, TGF-b, IGF binding protein 6, thymosin beta, diacylglycerol kinase alpha and neuronal growth related genes were substantially induced and were among the primary targets suggesting that these genes may also be relevant to the tumor suppressive phenotype induced by p53 as are the classical cell cycle related p53 inducible genes. Further analysis and cataloguing of p53 primary target genes from various cell lines may explain how p53 orchestrates diverse cellular signals as a tumor suppressor and could possibly lead to the identi®cation of potential therapeutic molecular targets for therapy in dierent cellular targets. The approach presented here of de®ning primary targets of p53 is an important additional step in sorting out p53 targets at various cellular contexts.
Materials and methods
Cell lines, cycloheximide treatment and total RNA isolation
The human lung cancer cell line H1299 (lacking endogenous p53) expressing the mouse temperature sensitive mutant p53Val135 (a gift of Dr M Oren) which on temperature shift to 328C will assume wild-type p53 conformation was used in this study. The control cell line used was the parental H1299 cells without ts-p53Val135. The cells were maintained at 378C in RPMI medium containing 10% fetal bovine serum (FBS). Where speci®ed, the cells were exposed to cycloheximide (10 mg/ml) 30 min prior to temperature shift. The cells were temperature shifted to 328C, and after speci®c time intervals, harvested in TRIZOL solution (Gibco BRL, USA) and total RNA was isolated as per manufacturer's instructions.
Northern and Western-blot analyses
Equal amounts (10 mg) of total cellular RNA were used for Northern-blot analysis, using standard protocols (Ausubel et al., 1990) . Autoradiography was done on Kodak X-ray ®lms with intensifying screens at 7708C. For Western-blots, total cell lysates were prepared by lysing cells in NP40 lysis buer (0.5% NP40, 150 mM NaCl, 50 mM Tris-Cl, pH 7.5, 1 mM DTT, 25 ng/ml aprotinin, 25 ng/ml leupeptin and 1 mM PMSF). Equal amounts (60 mg) of total protein were fractionated by SDS ± PAGE on a 15% gel and transferred to nitrocellulose membranes (BA.85, Schleicher and Schuell). The primary antibodies used was a mixture of mAbs 421/248 for p53, Ab C19 (Santa Cruz) for p21 and a mixture of mAbs 4B2/2A9 for human MDM2 protein. The secondary antibodies used were HRP goat anti-mouse IgG (Sigma) and HRP goat anti-rabbit IgG (Jackson Laboratories).
Preparation of labeled cRNA and hybridization of microarrays
Total RNA was isolated from H1299val135 cells incubated at 328C for 2, 6, 12, 24 h and H1299 control cells at 328C for 2, 12 h. H1299val135 cells at 328C in the presence of cycloheximide were harvested only up to 12 h at 2, 4, 6, 9 and 12 h time points and H1299 control cells with cycloheximide at 328C were harvested at 2 h time point and total RNA was isolated. Biotin labeled cRNA was synthesized and hybridized as described (Kaminski et al., 2000) to the Genechip HuGene FL array (Aymetrix, Santa Clara, USA) which contains probes for *7000 human genes. Scanned output ®les were visually inspected for hybridization artifacts. Arrays lacking signi®cant artifacts were analysed using Genechip 3.3 software (Aymetrix). Arrays were scaled to an average intensity of 1200 per gene and analysed independently. The expression value for each gene was determined by calculating the average of dierences (perfect match intensity minus mismatch intensity) of the probe pairs in use for this gene. Ratios were determined by dividing the average dierence of H1299Val135 cells for each time point to that of H1299 control cells at 2 h time point with or without cycloheximide in the respective experiments. A value of 100 was assigned to all measurements lower than 100. The expression data for all the hybridization experiments can be obtained from the corresponding author upon request.
Clustering analysis
Clustering analysis was performed twice; ®rst to the 259 genes that were upregulated over 2.5-fold at least three times in the absence of CHX (in at least one of the three experiments, the gene had to be`present' in the Present/ Absent call provided by Aymetrix software). The second clustering analysis was applied to the 1090 genes that were upregulated over twofold at least once, in the absence of CHX experiment (also in that experiment it should be called present'). In both cases, each gene was represented by nine (four experiments without CHX and ®ve experiments with CHX) values representing the log ratio of the average dierence in the experiments to the average dierence in their corresponding control. The log ratios were then normalized for each gene by dividing separately for the two experiments. The clustering algorithm measured the distance between the genes using the regular Euclidean distance between their normalized values. Note that this distance measure is more suitable than the Pearson correlation between the log ratios, since the latter may place induced and repressed genes in the same cluster.
